AMINOGLUTETHIMIDE AS 2ND-LINE ENDOCRINE TREATMENT IN METASTATIC BREAST-CANCER

被引:7
|
作者
PRONZATO, P
ARDIZZONI, A
LIONETTO, R
CONTE, P
ROSSO, R
机构
关键词
D O I
10.1177/030089168507100313
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:297 / 300
页数:4
相关论文
共 50 条
  • [1] USE OF AMINOGLUTETHIMIDE AS 2ND-LINE ENDOCRINE THERAPY IN METASTATIC BREAST-CANCER
    KAYE, SB
    WOODS, RL
    FOX, RM
    COATES, AS
    TATTERSALL, MHN
    CANCER RESEARCH, 1982, 42 (08) : 3445 - 3447
  • [2] EFFECTIVENESS AND UTILITY OF A 2ND-LINE TREATMENT IN METASTATIC BREAST-CANCER
    PORZSOLT, F
    MAYERSTEINACKER, R
    EGGL, C
    ONKOLOGIE, 1995, 18 (01): : 48 - 52
  • [3] AMINOGLUTETHIMIDE AS 2ND LINE ENDOCRINE THERAPY IN ADVANCED BREAST-CANCER
    BRUFMAN, G
    BIRAN, S
    ANTICANCER RESEARCH, 1986, 6 (05) : 1065 - 1068
  • [4] MITOXANTRONE AS 2ND-LINE SINGLE AGENT IN METASTATIC BREAST-CANCER
    STEIN, M
    BOROVIK, R
    ROBINSON, E
    ONCOLOGY, 1991, 48 (04) : 265 - 269
  • [5] IMPACT OF 2ND-LINE THERAPIES ON SURVIVAL IN METASTATIC BREAST-CANCER
    FRYE, D
    HORTOBAGYI, GN
    BUZDAR, AU
    BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (01) : 124 - 124
  • [6] AMINOGLUTETHIMIDE AS 2ND-LINE HORMONAL-THERAPY IN ADVANCED BREAST-CANCER - RESPONSE AND TOXICITY
    ROWELL, NP
    GILMORE, OJA
    PLOWMAN, PN
    HUMAN TOXICOLOGY, 1987, 6 (03): : 227 - 232
  • [7] 2ND-LINE CHEMOTHERAPY WITH MITOXANTRONE AS A SINGLE AGENT IN METASTATIC BREAST-CANCER
    BRUFMAN, G
    HAIM, N
    BENBARUCH, N
    SULKES, A
    JOURNAL OF CHEMOTHERAPY, 1993, 5 (01) : 43 - 46
  • [8] AMINOGLUTETHIMIDE IN THE TREATMENT OF METASTATIC BREAST-CANCER
    TRONER, MB
    CANCER RESEARCH, 1982, 42 (08) : 3402 - 3404
  • [9] AMINOGLUTETHIMIDE TREATMENT OF METASTATIC BREAST-CANCER
    ASBURY, RF
    BAKEMEIER, RF
    FOLSCH, E
    SAVLOV, E
    BENNETT, JM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 305 - 305
  • [10] 2ND LINE HORMONAL-THERAPY WITH AMINOGLUTETHIMIDE IN METASTATIC BREAST-CANCER
    BRUFMAN, G
    BIRAN, S
    ACTA ONCOLOGICA, 1990, 29 (06) : 717 - 720